about
Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective.Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged miceRetinal ganglion cell dendritic atrophy in DBA/2J glaucomaUsing genetic mouse models to gain insight into glaucoma: Past results and future possibilities.Mouse models of dominant optic atrophy: what do they tell us about the pathophysiology of visual loss?Neuroinflammation in glaucoma: A new opportunity.Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma.Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma.GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma.A Miniature, Fiber-Coupled, Wireless, Deep-Brain Optogenetic Stimulator.Opa1 is essential for retinal ganglion cell synaptic architecture and connectivity.Nicotinamide treatment robustly protects from inherited mouse glaucoma.A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.Jnk2 deficiency increases the rate of glaucomatous neurodegeneration in ocular hypertensive DBA/2J mice.Digestion of the glycosaminoglycan extracellular matrix by chondroitinase ABC supports retinal ganglion cell dendritic preservation in a rodent model of experimental glaucomaInhibition of monocyte-like cell extravasation protects from neurodegeneration in DBA/2J glaucomaSpecific deficits in visual electrophysiology in a mouse model of dominant optic atrophyMidget retinal ganglion cell dendritic and mitochondrial degeneration is an early feature of human glaucoma
P50
Q33719355-5211C344-6D20-4586-9C5B-F88F073ABA72Q34551476-D535C403-B918-4445-A980-B897A38C9F24Q34973759-ED0D0CB3-825E-4CCE-B88B-04C9FCEC3536Q36236937-AF051D97-7FD2-4D16-B6A9-49E12BD15C11Q37783778-E4C7C59F-8DE8-4F35-A94A-E776C78AED24Q39153080-1D539A19-7006-4ACC-956E-341446C3723EQ39904367-7DFF835B-6886-42CF-A7FF-97770A53097CQ42005958-40F05AA2-7F94-447E-89D9-57EBB0CA55D5Q42290385-F1E3893C-8EAF-4769-9800-036275C8AE75Q48366963-4397EA2C-D7D2-4F83-9690-F33C69A88BA7Q48679280-2D859A57-19D4-4DEF-86F9-9D76FFEAF1BCQ52678000-85DBAB85-135D-45B7-B2CE-511E53D4E5E0Q55157765-06780726-3EF8-4ABD-AB89-A4703D32FAF9Q55239846-FD2B189B-CC11-40EE-8193-907E6C7C9F8DQ59329699-F68E64BE-D138-4B25-92EF-3C8DF830FB29Q61445491-776919C0-5D95-46CF-8AE6-7B2ECE748C91Q84624622-93FBAD08-78A5-46E2-BDD3-210B19E51E37Q92366195-5CB004D7-3E26-4F32-AE40-89B44CF82217
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-6194-8397
@en
name
Pete A Williams
@ast
Pete A Williams
@en
Pete A Williams
@es
Pete A Williams
@nl
type
label
Pete A Williams
@ast
Pete A Williams
@en
Pete A Williams
@es
Pete A Williams
@nl
prefLabel
Pete A Williams
@ast
Pete A Williams
@en
Pete A Williams
@es
Pete A Williams
@nl
P106
P31
P496
0000-0001-6194-8397